1 / 29

Preterm Labour and PPORM

Preterm Labour and PPORM. Dr. Yasir Katib MBBS, FRCSC Perinatologest. Outline. Definition Burden of Illness Etiology & Risk Factors Diagnosis Management ?tocolytics ?antibiotics steroids. Preterm Labour: Definition.

amadis
Download Presentation

Preterm Labour and PPORM

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Preterm Labour andPPORM Dr. Yasir Katib MBBS, FRCSC Perinatologest

  2. Outline • Definition • Burden of Illness • Etiology & Risk Factors • Diagnosis • Management • ?tocolytics • ?antibiotics • steroids

  3. Preterm Labour: Definition • Regular uterine contractions + progressive cervical dilatation and/or effacement at < 37 weeks GA

  4. Burden of Illness: Incidence • Preterm delivery occurs in 12% pregnancies • 3-4% were <34 weeks • Those > 34 weeks born in tertiary care centres have survival rates = term • Long-term sequelae mainly in those born < 34 weeks • 70-80% occur spontaneously

  5. Burden of Illness: Significance • Preterm birth accounts for 75% of Perinatal mortality • Long-term sequelae include: • CNS & neurodeveopmental problems • respiratory • blindness and deafness • Significant physical psychological and financial burdens

  6. Survival in Extreme Preterm Delivery

  7. Long-term Morbidity of Extreme PTD MUMC < 29 weeks GA 1983 - 1988 n = 464 44% 50% 40% 31% 27% 30% 22% 20% 11% 9% 10% 0% 23 24 25 26 27 28 Gestational Age at Birth (weeks)

  8. Etiology & Risk Factors • Idiopathic • PPROM • Antepartum hemorrhage • Chorioamnionitis • Multiple pregnancy/polyhydramnios • Incompetent cervix/uterine anomaly • Maternal disease • Fetal Anomaly

  9. Prevention • No benefit has been demonstrated by attempts to prevent PTL with: • social interventions • bed rest • methods of cervical assessment • medications including betamimetics, magnesium, calcium • May be some increase in gestation with: • fish oil • progesterone injections • (need further study of both to show benefit)

  10. Diagnosis • Establish Due Date • Naegele’s Rule • U/S • 7-12 weeks: +/- 5d • 13-21 weeks: +/- 1wk • 22-30 weeks: +/- 2wk • 30+ weeks: +/- 3wk • (document clearly on assessments!)

  11. Diagnosis • History of contractions / risk factors • Abdo exam for contractions • Cervical exam – serial if necessary • 20-50% preterm labour diagnosis is incorrect • Vaginal fibronectin • Cervical U/S

  12. Management • Four Objectives: • 1. Early diagnosis • 2. ID and treat cause if possible • 3. Attempt to arrest Labour when appropriate • 4. Minimize neonatal morbidity and mortality

  13. Management Medications MgSO4 Ca channel blockers Cyclo-oxygenase inhibitors Oxytocin receptors antagonists Nitric oxcide

  14. Arresting Labour • Note: <40% patients in preterm labour are candidates for tocolysis • Goal of tocolysis: • get 48 hrs for steroids to have effect • transport

  15. Tocolysis • When NOT to tocolyse: • significant vaginal bleeding • suspected fetal asphyxia • intraamniotic infection • IUFD or lethal anomaly • maternal indication • imminent delivery

  16. Tocolysis: Options • ECPC: • no effect: • fluid bolus • ethanol • sedation • magnesium sulphate

  17. Tocolysis • ECPC: • Some effect: • betamimetics • calcium channel blockers • indomethacin • antimicrobials • oxytocin antagonists

  18. Antimicrobials: ORACLE II • Kenyon et al. Lancet 2001 Mar 31;357(9261):989-94 • Methods: • multicentre randomised controlled trial • 6295 women in preterm labour (diagnosis left to individual clinician) w/ IM, no evid infection & “substantial uncertainty as to whether antbiotics should be prescribed” • randomized to: • erythromycin • co-amoxiclav • both • placebo

  19. ORACLE II • Conclusion: • Abx should not be routinely prescribed in PTL w/o evidence of infection or PPROM

  20. Effect of Corticosteroids on Neonatal Outcomes RDS IVH NEC Perinatal Infection Neonatal Death 0.1 1 10 Odds Ratio (95% Confidence Interval) Crowley CCPC Review No. 02955

  21. Recommendations: NIH • NIH Consensus Statement JAMA Feb. 1, 1995 273:5:411-417. • fetuses 24-34 weeks w/ threatened PTL candidates for corticosteroids • pts eligible for toco should be eligible for steroids • Tx: betamethasone 12mg IM Q 24hr x 2 • Dexamethasone 6 mg IM Q 12 hr x 4 • Max benefit 24 hr – 7d, but.. • Give even if delivery anticipated w/in 24 hrs b/c some still beneficial

  22. Upper Gestational Limit • NIH 1995: give steroids to 24-34wks (adopted by SOGC 1995) • ALARM: 34-36 wks • UK Royal College of Obs and Gyn: up until 36 wks

  23. 100 80 60 RDS (%) 40 20 0 20 24 28 32 36 40 Gestational age (weeks) RDS - Incidence

  24. RDS: NNT

  25. GBS PROPHYLAXIS • The benefits of group B streptococcal (GBS) prophylaxis are well established. • Intrapartum prophylaxis should be initiated in any patient with an unknown GBS status or a history of a positive culture during the present pregnancy. • Treatment is not indicated if there was a recent negative anovaginal culture

  26. CDC RECOMMENDATIONS

  27. The effect of antibiotics on GBS Reduction ratio in GBS colonization after a single 2gm dose of IV ampicillin Time

  28. Take home points • Accurate diagnosis key • Dating • Really labour? • Tocolysis (where appropriate) • choices • Ca channel blocker • goals: • give corticosteroids (once) • transfer to appropriate level facility • To reduce neonatal mortality & morbidity: • Steroids

  29. THANK YOU

More Related